Product Information
CIPROFLOX-DEXAMETH OTIC SUSP is a generic product labeled by ARMAS PHARMACEUTICALS INC., priced at $7.1238 per ML under NDC 72485062513. Its NADAC has been published 125 times since May 15, 2024.
FDA first approved this application on Jun 9, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3; 1 mg/mL; mg/mL
Manufacturer
ARMAS PHARMACEUTICALS INC.NDC
72485062513
Classification
Generic
Dosage Form
SUSPENSION/ DROPS
Route
AURICULAR (OTIC)
Effective Date
9/23/2026
Active Ingredients
CIPROFLOXACIN HYDROCHLORIDE; DEXAMETHASONEApproval Type
Generic (ANDA)
FDA Application
ANDA215768FDA Approved
6/9/2023
TE Code
AB
On Market Since
11/1/2023
Pharmacological Classes
Price Statistics
The NADAC for CIPROFLOX-DEXAMETH OTIC SUSP has been published 125 times since May 15, 2024, and over the history we have for it it has declined 49.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.1238 per ML |
|---|---|
| All-time high | $16.6407 (Nov 13, 2024) |
| All-time low | $6.9454 (Aug 19, 2026) |
| 52-week high | $9.8982 |
| 52-week low | $6.9454 |
| Median price | $10.3150 |
| Average price | $10.8016 |
| Largest weekly change | -39.8% (Nov 20, 2024) |
| Weeks tracked | 125 |
| Tracking since | May 15, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ARMAS PHARMACEUTICALS INC. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ciprofloxacin and dexamethasone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CIPROFLOX-DEXAMETH OTIC SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CIPROFLOX-DEXAMETH OTIC SUSP, manufactured by ARMAS PHARMACEUTICALS INC., is $7.1238 per ML (NDC 72485062513), effective Sep 30, 2026.
How has the price of CIPROFLOX-DEXAMETH OTIC SUSP changed over time?
Over the history we have for it, the NADAC for CIPROFLOX-DEXAMETH OTIC SUSP has declined 49.5%. It has been tracked across 125 weekly CMS publications since May 15, 2024.
What are the highest and lowest recorded NADAC prices for CIPROFLOX-DEXAMETH OTIC SUSP?
Since May 15, 2024, the NADAC for CIPROFLOX-DEXAMETH OTIC SUSP has ranged from a low of $6.9454 (Aug 19, 2026) to a high of $16.6407 (Nov 13, 2024), with a median of $10.3150 per ML.
Are there cheaper alternatives to CIPROFLOX-DEXAMETH OTIC SUSP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CIPROFLOX-DEXAMETH OTIC SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures CIPROFLOX-DEXAMETH OTIC SUSP?
CIPROFLOX-DEXAMETH OTIC SUSP (NDC 72485062513) is labeled by ARMAS PHARMACEUTICALS INC., and CMS classifies it as a generic product.